Skip to main content
Jessica (Mckay) Castle, MD, Endocrinology, Portland, OR, Portland HCS

JessicaRose(Mckay)CastleMD

Endocrinology Portland, OR

Diabetes, Lipid Metabolism

Assistant Professor, Medicine, Oregon Health and Science University School of Medicine. Preventative Cardiology

Dr. Castle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Castle's full profile

Already have an account?

Education & Training

  • Oregon Health & Science University
    Oregon Health & Science UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2010
  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Internal Medicine, 2004 - 2007
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 2004
  • University of Oregon’s Robert Donald Clark Honors College
    University of Oregon’s Robert Donald Clark Honors CollegeBA, 2000

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2006 - 2025
  • WA State Medical License
    WA State Medical License 2022 - 2025
  • MN State Medical License
    MN State Medical License 2021 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Most Outstanding Curriculum Block OHSU Medical School, 2016
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Medical Housestaff Teaching Award 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Randomized Trial of a Dual-hormone Artificial Pancreas with Dosing Adjustment During Exercise Compared with No Adjustment and Sensor-augmented Pump Therapy  
    Jacobs P, El Youssef J, Reddy R, Resalat N, Branigan D, Condon J, Preiser N, Ramsey K, Jones M, Edwards C, Kuehl K, Leitschuh J, Rajhbeharrysing U, Castle JR, Diabetes, Obesity and Metabolism, 1/1/2016
  • Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon vs Lyophilized Glucagon in Type 1 Diabetes Subjects  
    Castle JR, El Youssef J, Branigan D, Newswanger B, Strange P, Cummins M, Shi L, Prestrelski S, J Diabetes Sci Technol, 1/1/2016
  • Non-adjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions  
    Castle JR, Jacobs PG, J Diabetes Sci Technol, 1/1/2016
  • Join now to see all

Abstracts/Posters

  • Comparative PK/PD Study of Liquid Stable G-Pump Glucagon vs. Novo Nordisk Glucagen Delivered to T1DM Patients via an Omnipod Pump
    Castle JR, Advanced Technologies and Treatments for Diabetes, 1/1/2015
  • The Use of Redundant Dexcom New Generation Sensors to Assess Sensor Accuracy and Performance
    Castle JR, Diabetes Technology Meeting, 1/1/2012
  • Assessment of Hepatic Glycogen Using Magnetic Resonance Spectroscopy: Implications for Bi-hormonal Artificial Pancreas
    Castle JR, American Diabetes Association 72nd Scientific Session, 1/1/2012
  • Join now to see all

Lectures

  • Is Mini-Dose Glucagon the Answer to Preventing Exercise-Related Dysglycemia? 
    Portland, OR - 6/14/2014
  • Hypoglycemia 
    1/1/2017
  • Glucose Homeostasis 
    OHSU School of Medicine - 1/1/2017
  • Join now to see all

Other

  • Monitoring and Preventing Complications 
    Castle JR, HealthSmart Webinar
    1/1/2015

Press Mentions

  • Georgia and Its Hospitals Scramble to Prepare for Coronavirus Surge
    Georgia and Its Hospitals Scramble to Prepare for Coronavirus SurgeApril 1st, 2020
  • Oregonians with Diabetes Facing Tough Choices as Insulin Prices Soar
    Oregonians with Diabetes Facing Tough Choices as Insulin Prices SoarFebruary 4th, 2019
  • Xeris Pharmaceuticals Kicks off Dual-Hormone Artificial Pancreas Trial
    Xeris Pharmaceuticals Kicks off Dual-Hormone Artificial Pancreas TrialAugust 20th, 2018
  • Join now to see all

Hospital Affiliations